We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Cancer cells.
Product News

Xsphera Biosciences and NEX-I Collaborate To Advance Oncology Drug Research

Xsphera Biosciences, is pleased to announce the formalization of a Memorandum of Understanding (MOU) with NEX-I, a Seoul-based pioneer in immune-oncology therapeutics.
DNA bases.
Product News

Beckman Coulter Life Sciences and Pillar Biosciences Announce NGS Application Development Pipeline

Assays focus on accelerating cancer research.
A doctor holding a clipboard with a patient.
Product News

OncoHost To Present Proteomics-Based Predictive Biomarker for Immune-Related Adverse Events in NSCLC Patients

Novel computational model accurately predicts significant irAEs in NSCLC patients based on proteomic profiling of one pre-treatment blood test.
Double helix structure of DNA.
Product News

Thermo Fisher Scientific Signs Companion Diagnostic Agreement With Boehringer Ingelheim

Collaboration leverages two CDx assays from Thermo Fisher to support greater access to genomic testing for cancer patients in Japan and the United States.
A hand holding an Eppendorf tube with the letters representing DNA bases in the background.
Product News

Mayo Clinic and Oxford Nanopore Announce Collaboration

Joint development collaboration to bring leading-edge nanopore sequencing into clinical laboratories at Mayo Clinic to increase understanding and improve treatment of cancer and genetic disorders.
Cancer cells.
Product News

CELLINK & Carcinotech Partner to Personalize Cancer Drug Development

Carcinotech and CELLINK plan to revolutionize the drug discovery market by leveraging CELLINK’s bioprinting solutions and Carcinotech’s expertise in producing 3D bioprinted living tumors to provide protocols for users to develop cutting-edge cancer models.
A scientist holding a rack of blood samples.
Product News

Sebia Launches M-InSight®, a Test for Monitoring Multiple Myeloma Patients

Corgenix, a Sebia Group company, CAP/CLIA clinical laboratory, positions Sebia to globally commercialize M-inSight®, a novel non-invasive liquid biopsy assay for Minimal Residual Disease (MRD) monitoring in multiple myeloma.
Representation of human cells.
Product News

Curiox Biosystems To Advance Next-Generation Cancer Cell Therapies Through Collaboration With Leading Cancer Researcher

Curiox Biosystems announces its collaboration with Dr. Marco Ruella, an assistant professor of medicine at the Perelman School of Medicine, to support efforts in the development of next-generation cancer cell therapies.
Cancer cells.
Product News

Orano Med and Orbit Discovery Enter Collaboration To Discover Novel Targeted Radioligand Therapies for Cancer

Orano Med SAS, and Orbit Discovery Ltd, announced that they have entered into a collaboration to discover specific Peptide Receptor Radionuclide Therapies against cancer cells and advance the development of novel radiopharmaceuticals.
Immunohistochemistry on a human breast cancer tissue microarray.
Product News

Custom Monoclonal Antibody Reveals Promising HER2+ Breast Cancer Target

AMSBIO has supplied a custom monoclonal antibody (mAB) to researchers at the TU Dortmund** in Germany to unravel the role of EDI3 in breast cancer development.
Advertisement